{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:58:11Z","timestamp":1792760291267,"version":"4.5.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>The classification of extraovarian disease into invasive and noninvasive implants predicts patient outcome in patients with high-stage ovarian serous borderline tumors (tumors of low malignant potential). However, the morphologic criteria used to classify implants vary between studies. To date, there has been no large-scale study with follow-up data comparing the prognostic significance of competing criteria. Peritoneal and\/or lymph node implants from 181 patients with high-stage serous borderline tumors were evaluated independently by 3 pathologists for the following 8 morphologic features: micropapillary architecture; glandular architecture; nests of epithelial cells with surrounding retraction artifact set in densely fibrotic stroma; low-power destructive tissue invasion; single eosinophilic epithelial cells within desmoplastic stroma; mitotic activity; nuclear pleomorphism; and nucleoli. Follow-up of 156 (86%) patients ranged from 11 to 264 months (mean, 89 mo; median, 94 mo). Implants with low-power destructive invasion into underlying tissue were the best predictor of adverse patient outcome with 69% overall and 59% disease-free survival (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01). In the evaluation of individual morphologic features, the low-power destructive tissue invasion criterion also had excellent reproducibility between observers (\u03ba=0.84). Extraovarian implants with micropapillary architecture or solid nests with clefts were often associated with tissue invasion but did not add significant prognostic value beyond destructive tissue invasion alone. Implants without attached normal tissue were not associated with adverse outcome and appear to be noninvasive. Because the presence of invasion in an extraovarian implant is associated with an overall survival analogous to that of low-grade serous carcinoma, the designation low-grade serous carcinoma is recommended. Even though the low-power destructive tissue invasion criterion has excellent interobserver reproducibility, it is further recommended that the presence of an invasive implant be confirmed by at least 2 pathologists (preferably at least 1 of whom is an experienced gynecologic pathologist) in order to establish the diagnosis of-low grade serous carcinoma.<\/jats:p>","DOI":"10.1097\/pas.0000000000000692","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T15:29:55Z","timestamp":1468510195000},"page":"1155-1164","source":"Crossref","is-referenced-by-count":43,"title":["Classification of Extraovarian Implants in Patients With Ovarian Serous Borderline Tumors (Tumors of Low Malignant Potential) Based on Clinical Outcome"],"prefix":"10.1097","volume":"40","author":[{"given":"Jesse K.","family":"McKenney","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[{"name":"Vancouver General Hospital and University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kalloger","sequence":"additional","affiliation":[{"name":"Vancouver General Hospital and University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri A.","family":"Longacre","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","article-title":"Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators","volume":"31","author":"Seidman","year":"2000","journal-title":"Hum Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/1097-0142(19881115)62:10<2212::AID-CNCR2820621024>3.0.CO;2-W","article-title":"Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis","volume":"62","author":"Bell","year":"1988","journal-title":"Cancer"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/00000478-200104000-00001","article-title":"Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas","volume":"25","author":"Bell","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/1097-0142(19900201)65:3<578::AID-CNCR2820650332>3.0.CO;2-N","article-title":"Serous ovarian tumors of low malignant potential with peritoneal implants","volume":"65","author":"Gershenson","year":"1990","journal-title":"Cancer"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1096::AID-CNCR13>3.0.CO;2-1","article-title":"Ovarian serous borderline tumors with invasive peritoneal implants","volume":"82","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D","article-title":"Serous borderline tumors of the ovary with noninvasive peritoneal implants","volume":"83","author":"Gershenson","year":"1998","journal-title":"Cancer"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/1097-0142(19860315)57:6<1240::AID-CNCR2820570630>3.0.CO;2-L","article-title":"Invasive and noninvasive implants in ovarian serous tumors of low malignant potential","volume":"57","author":"Michael","year":"1986","journal-title":"Cancer"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2559.1984.tb02336.x","article-title":"Peritoneal epithelial lesions associated with proliferative serous tumours of ovary","volume":"8","author":"McCaughey","year":"1984","journal-title":"Histopathology"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.humpath.2004.03.005","article-title":"Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives","volume":"35","author":"Bell","year":"2004","journal-title":"Hum Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004347-200301000-00008","article-title":"Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases","volume":"22","author":"Gilks","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00000478-200205000-00005","article-title":"A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component","volume":"26","author":"Slomovitz","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ajcp\/114.3.380","article-title":"Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients","volume":"114","author":"Goldstein","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200209000-00002","article-title":"Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion","volume":"26","author":"Prat","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000478-199904000-00004","article-title":"Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns","volume":"23","author":"Eichhorn","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00000478-199611000-00003","article-title":"Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors","volume":"20","author":"Burks","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0046-8177(90)90201-F","article-title":"Ovarian serous borderline tumors with stromal microinvasion: a report of 21 cases","volume":"21","author":"Bell","year":"1990","journal-title":"Hum Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1097\/01.pas.0000213299.11649.fa","article-title":"Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00000478-200604000-00005","article-title":"Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma","volume":"30","author":"Rollins","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/01.pas.0000194743.33540.e6","article-title":"Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification","volume":"30","author":"McKenney","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R21-20230922","first-page":"189","article-title":"Annual report on the results of treatment in gynecological cancer","volume":"28","year":"1989","journal-title":"Int J Gynecol Obstet"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00000478-200209000-00003","article-title":"Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases","volume":"26","author":"Deavers","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000000693","article-title":"Low-grade serous carcinoma of the ovary: clinicopathologic analysis of 60 intraepithelial and invasive cases","author":"Ahn","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ygyno.2007.01.030","article-title":"Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma","volume":"105","author":"Shvartsman","year":"2007","journal-title":"Gynecol Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:23:25Z","timestamp":1695421405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201609000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000692","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}